FindTrial
Sign In

Oral gabapentin to prevent postsurgical pain

To evaluate the role of gabapentin as a pre-emptive analgesia in patients undergoing laparoscopic hernia repair

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017494
Enrollment
100
Registered
2019-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: group A: 300mg gabapentin orally 2hrs prior to surgery Intervention2: Gabapentin: 300mg orally 2 hours before surgery Control Intervention1: Placebo: oral 2 hours prior to sugery

Sponsors

SIBHA SD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1 &2 informed consent

Exclusion criteria

Exclusion criteria: patient refusal, chronic pain syndrome, known seizure/ psychiatric disorder, drug abuse already on gabapentin/ pregablin

Design outcomes

Primary

MeasureTime frame
to evaluate gabapentin when given orallyin the preoperative period at a dose of 300mg has an effect on postoperative pain and analgesic requirementsTimepoint: At various intervals of 0, 2, 6, 12, 24 hours postoperatively—

Secondary

MeasureTime frame
adverse events .Timepoint: 24hours postoperative period—

Countries

India

Contacts

Public ContactSibha SD

KMCH

drharendra2001@gmail.com9560746789

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026